Tong‐Chun Xue

1.7k citations
41 papers · 1.3k indexed · h-index 22
Topics
Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Bone and Dental Protein Studies (7 papers)Inflammatory Biomarkers in Disease Prognosis (5 papers)
Partner nations
ChinaEthiopiaIndia

In The Last Decade

Tong‐Chun Xue

40 papers receiving 1.3k citations

Peers

Tong‐Chun Xue
Comparison fields: 5 of 83
  • Oncology 501
  • Molecular Biology 466
  • Hepatology 405
  • Cancer Research 321
  • Epidemiology 208
Replace Shuhei Yoshida with:
Shuhei Yoshida Japan
Arsen Mikaelyan Russia
Joanna W. Ho Hong Kong
Richard Sharp United States
Zhenggang Ren China
Nigel C. Bird United Kingdom
Andrea Malfettone Spain
Hien Dang United States
Qiong Xue China
Kejun Nan China
Tong‐Chun Xue relative to Shuhei Yoshida Japan Shuhei Yoshida's profile →
Citations per field
00.5×1.5×1.9×
Shuhei Yoshida · 1×
Citations per year

Countries citing papers authored by Tong‐Chun Xue

Since Specialization
Citations

This map shows the geographic impact of Tong‐Chun Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tong‐Chun Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tong‐Chun Xue more than expected).

Fields of papers citing papers by Tong‐Chun Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tong‐Chun Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tong‐Chun Xue. The network helps show where Tong‐Chun Xue may publish in the future.

Co-authorship network of co-authors of Tong‐Chun Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Tong‐Chun Xue. A scholar is included among the top collaborators of Tong‐Chun Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tong‐Chun Xue. Tong‐Chun Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 17
3 2
4 18
5 112
6 10
7 6
8 33
9 44
10 21
11 40
12 16
13 12
14 102
15 30
16 26
17 130
18 15
19 27
20 26

About Tong‐Chun Xue

Tong‐Chun Xue is a scholar working on Hepatology, Oncology and Cancer Research, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Bone and Dental Protein Studies (7 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). The work is most often cited by research in Hepatology (405 citations), Cancer Research (321 citations) and Oncology (501 citations). Tong‐Chun Xue has collaborated with scholars based in China, Ethiopia and India. Frequent co-authors include Zhenggang Ren, Sheng‐Long Ye, Rongxin Chen, Lan Zhang, Boheng Zhang, Jiefeng Cui, Xiaoying Xie, Ningling Ge, Dongmei Gao and Qiongdan Zheng. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026